Searched for
INDIA DRUG REGULATORY REVIEW
Regulator flags unauthorised mfg & sale of male infertility drugIndia’s drug regulator has directed states to crack down on the unauthorised manufacture and sale of Enclomiphene products. CDSCO said the ...- Regulator mandates full review of globally unapproved drugsIndia’s drug regulator has clarified that new drugs not approved anywhere globally must undergo the full domestic regulatory process, even ...
- Bombay HC warns Maharashtra FDA for ‘sword to kill mosquito’ approach as Cadila challenges drug banThe Bombay High Court criticized the Maharashtra FDA for its drastic actions against companies. The court directed the regulator to grant h...
- For MSMEs, compliance is becoming a test of operational readiness, not just paperworkMSMEs often have filings in place, but they struggle with contractor compliance, licence renewals, workplace safety, and inspection readine...
- Eli Lilly’s Foundayo becomes first oral weight-loss drug approved in UK for diabetesBritain's regulator approved Eli Lilly's Foundayo pill for weight and diabetes. This treatment is not yet available through the NHS in the ...
- Medical devices are not pharma products, companies say while opposing Draft BillIndia’s medical device industry and healthcare groups have opposed the draft Drugs, Medical Devices and Cosmetics Bill, 2026, arguing that ...
- Supreme Court seeks Centre's reply on plea for time-bound probe and speedy trial in drug-trafficking casesThe Supreme Court has sought responses from the Centre on strengthening drug trafficking efforts. It called for time-bound probes and trial...
- Independence Day 2026: India, which once couldn't make smallpox vaccine, has now crossed a pharma milestone the world can't ignore2026 Independence Day: India's pharmaceutical industry marks a historic milestone with a new drug approval. This achievement reflects decad...
- Akums Drugs shares rally 9% hit 52-week high after Q1 results; stock up 67% YTDAkums Drugs shares rose sharply on Monday to hit a 52-week high after the company reported strong Q1 FY27 results. Revenue rose 13.9% year-...
- Picking the right pharma stock is getting harder; so pick a portfolio: 20 stocks with -23% to +22% downside to upside potentialFor Indian pharma, the regulatory risk is still real. A US FDA inspection can still cause trouble. A plant making an important product or g...
- Western states, UTs forge joint strategy against cybercrime, drug cartelsPolice chiefs from seven western states met to devise a joint strategy. They finalized security arrangements for the 2028 Ujjain Simhastha ...
- India must build export-oriented medical devices industry, says pharma secretaryTo bolster India's medical device industry, a strategic pivot toward international markets and enhanced global presence is essential. Foste...
- Forget Nvidia chips, China's next big race is being slowed down by an unlikely rival: monkeysLab primate prices in China have surged over 1,000% in eight years, with a single cynomolgus macaque now costing around Rs 22 lakh. The sho...
- India to launch digital gold regulatory framework next yearThe Indian government is likely to roll out regulations for digital gold in the coming year, backed by discussions involving critical minis...
- Govt plans new drugs law to overhaul pharma, medical device regulationThe government is set to replace the 1940 Drugs and Cosmetics Act with a new law covering drugs, medical devices and cosmetics. The draft b...
- Centre to bar drugmakers from selling mislabelled, fraudulently approved products under new provisionsNew rules will bar drugmakers from selling products if false information was provided. The Union Ministry of Health & Family Welfare has am...
- New framework to standardise interest rate rules on the anvil, says RBIThe Reserve Bank of India plans to standardize interest rate rules for all regulated entities. This new principle-based framework aims to i...
- IPA seeks to regularise 'legacy' drugsThe Indian Pharmaceutical Alliance seeks to regularize many drugs. These drugs have been marketed for years without central approval. Examp...
- Government tightens surveillance on GLP-1 weight-loss drug promotion amidst surrogate advertising concernsCentral government directs state regulators to enhance surveillance over GLP-1 drug promotion. Approved GLP-1 drugs are only for Type 2 dia...
- India takes action against 90% of inspected high-risk pharmaceutical facilities, regulator saysAmid increasing global concerns over Indian pharmaceuticals, India's drug regulator is rigorously addressing high-risk manufacturing sites....
Load More
